# OnCo record arpi (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/arpi/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "arpi" ;
  schema:name "Androgen receptor pathway inhibitor (ARPI)"@en ;
  schema:alternateName "ARPI"@en, "ARPIs"@en, "ARSI"@en, "androgen receptor signalling inhibitor"@en, "androgen receptor pathway inhibitor"@en, "novel hormonal agent"@en, "NHA"@en, "next-generation antiandrogen"@en, "second-generation antiandrogen"@en, "AR antagonist"@en, "AR inhibitor"@en, "antiandrogen"@en, "anti-androgen"@en, "AR-V7"@en, "AR-targeted"@en, "AR antagonists"@en ;
  schema:description "The newer prostate cancer hormone pills (abiraterone, enzalutamide, apalutamide, darolutamide) that block the androgen receptor or the last steps of androgen production, used on top of standard testosterone suppression."@en ;
  schema:url <https://onco.cc/terms/arpi/> ;
  schema:dateModified "2026-09-09"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Antiandrogen> ;
  schema:citation <https://en.wikipedia.org/wiki/Antiandrogen> ;
  onco:related <https://onco.cc/terms/adt/>, <https://onco.cc/terms/castration-resistance/> ;
  onco:cancers <https://onco.cc/cancers/prostate/> ;
  onco:sections <https://onco.cc/fronts/hormonal/> ;
  onco:targets <https://onco.cc/targets/androgen-receptor/> ;
  onco:drugs <https://onco.cc/drugs/abiraterone/>, <https://onco.cc/drugs/enzalutamide/>, <https://onco.cc/drugs/bicalutamide/> ;
  onco:trials <https://onco.cc/trials/latitude/> .